Canalblog
Suivre ce blog Administration + Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
statistics
4 mai 2015

NEWS DRY EYE UPTO MAY 4TH 2015

NEWS DRY EYE UPTO MAY 4TH 2015
PubMed Ther Clin Risk Manag. 2015 Apr 13;11:595-603. doi: 10.2147/TCRM.S77091. eCollection 2015. http://www.ncbi.nlm.nih.gov 1. Clin Ophthalmol. 2015 Apr 15;9:665-75. doi: 10.2147/OPTH.S78184. eCollection 2015. Efficacy and safety of two new formulations...
Publicité
Publicité
25 avril 2015

EVALUATION OF TOPICAL ADMINISTRATIONS OF ML7 IN A RAT MODEL OF SCOPOLAMINE-INDUCED DRY EYE. SIGNED REPORT.

EVALUATION OF TOPICAL ADMINISTRATIONS OF ML7 IN A RAT MODEL OF SCOPOLAMINE-INDUCED DRY EYE. SIGNED REPORT.
Contract Research Organization: Ophthalmology Research - Iris Pharma Iris Pharma, a Contract Research Organization, provides preclinical and clinical research in ophthalmology: ocular safety, efficacy, ocular pharmacokinetics, clinical trials, bioanalytical...
6 avril 2015

New publications as April 6th, 2015

New publications as April 6th, 2015
PUBLICATIONS UP TO APRIL 6TH 2015 1. Acta Ophthalmol. 2015 Apr 2. doi: 10.1111/aos.12710. [Epub ahead of print] Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Anitua E 1, Muruzabal F, Tayebba A,...
8 janvier 2015

Study IRIS Pharma: evaluation of effectiveness of eye drop ML7 formulation in a rat modele of scopolamine-induced dry eye

Study IRIS Pharma: evaluation of effectiveness of eye drop ML7 formulation in a rat modele of scopolamine-induced dry eye
COMPTE RENDU DE L'ÉTUDE D'EFFICACITÉ 1. Summary Purpose: The aim of the study was to evaluate the therapeutic potential of topical applied ML7 formulation in a rat model of scopolamine-induced dry eye. Method: Dry eye symptoms were induced in albino Lewis...
Publicité
Publicité
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 342
Publicité